Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis

BACKGROUND: First-line treatments for nonsmall cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations have been evaluated in various clinical trials. However, it remains unclear which is the optimal treatment. METHODS: A Bayesian network meta-analysis was used to assess...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Med Oncol
Main Authors: Zhang, Zhonghan, Zeng, Kangmei, Zhao, Shen, Zhao, Yuanyuan, Hou, Xue, Luo, Fan, Lu, Feiteng, Zhang, Yaxiong, Zhou, Ting, Ma, Yuxiang, Yang, Yunpeng, Fang, Wenfeng, Huang, Yan, Zhang, Li, Zhao, Hongyun
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2019
Assuntos:
Meta-Analysis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937538/
https://ncbi.nlm.nih.gov/pubmed/31908655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919891652
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares